Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR PREPARING 2-FLUORO-2-METHYLDEOXYNUCLEOSIDE AS AN INTERMEDIATE OF SOFOSBUVIR
Document Type and Number:
WIPO Patent Application WO/2018/045997
Kind Code:
A1
Abstract:
The present application falls within the field of drug synthesis, and relates to a method for preparing 2-fluoro-2-methyldeoxynucleoside as an intermediate of Sofosbuvir. In particular, the present application provides a method for preparing a compound of formula V from a compound of formula II, and the intermediates used. The preparation method of the present application stereoselectively obtains the compound of formula V as β isomer in a condensation reaction, can be used for increasing the yield of a synthetic route of the intermediate of Sofosbuvir, i.e. the compound of formula 1, has a low process route cost and is more suitable for industrial scale-up.

Inventors:
KONG RUI (CN)
YUAN ZHEDONG (CN)
GUO MENG (CN)
HU MINGTONG (CN)
WANG DUZHENG (CN)
QIANG BIN (CN)
Application Number:
PCT/CN2017/101078
Publication Date:
March 15, 2018
Filing Date:
September 08, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI DUDE MEDICAL SCIENCE AND TECH CO LTD (CN)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07H19/06; C07D307/33; C07D317/30; C07H1/00; C07H13/06
Domestic Patent References:
WO2013178571A12013-12-05
WO2011005860A22011-01-13
WO2017077552A12017-05-11
Foreign References:
CN106146585A2016-11-23
Other References:
MICHAEL, J. SOFIA ET AL.: "Discovery of a beta -D-20-Deoxy-20-r-fluoro-20- beta -C-methyluridin Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus", JOURNAL OF MEDICINAL CHEMISTRY, vol. 53, no. 19, 16 September 2010 (2010-09-16), pages 7204 - 7218, XP055004442
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF: